Q-Line Biotech's IPO sparks debate on valuation sustainability amid recent profits boost

Q-Line Biotech’s recent IPO attracted intense investor interest, but questions remain over whether the company’s elevated valuation accounts for recent profit improvements and its lack of listed peers, raising the stakes for future growth and margins. Q-Line Biotech’s public issue…













